2026-2030年全球多種分析方法市場

全球多重檢測市場預計將從 2025 年到 2030 年成長至 14.148 億美元，預測期內複合年成長率為 7.2%。

本報告對全球多重檢測市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和成長要素以及整體市場環境進行了最新分析。推動該市場成長的因素包括精準醫療方法的日益普及、慢性病盛行率的上升以及對早期診斷和預防醫學日益重視。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，多重檢測技術與數位化和自動化檢查室生態系統的整合是未來幾年全球多重檢測市場成長的關鍵促進因素之一。此外，太空生物學和多體學研究應用領域的不斷拓展，以及對客製化、應用特定檢測方案日益成長的需求，預計也將帶來巨大的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球多元分析市場
• 按類型分類的細分市場分析，2020-2024 年
• 產品細分市場分析，2020-2024 年
• 2020-2024年基於技術的細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球多元分析市場
• 地緣政治衝突的影響：多種分析方法的全球市場

第7章：五力分析

第8章 市場區隔：依類型

• 比較：按類型
• 蛋白質多重檢測
• 核酸多重檢測
• 基於細胞的多重檢測
• 市場機會：按類型分類

第9章 市場區隔：依產品

• 比較：按產品
• 消耗品
• 設備和配件
• 服務
• 市場機會：依產品分類

第10章 市場區隔：依技術分類

• 比較：按技術
• 流式細胞技術
• 多重即時PCR
• 其他
• 市場機會：依技術分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 阿根廷
  • 哥倫比亞
  • 南非
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Abbott Laboratories
• Agilent Technologies Inc.
• Bio Rad Laboratories Inc.
• BioMerieux SA
• DiaSorin SpA
• Eurofins Scientific SE
• Hologic Inc.
• Meso Scale Diagnostics LLC
• Miltenyi Biotec BV and Co. KG
• QIAGEN NV
• Revvity Inc.
• Sartorius AG
• Siemens Healthineers AG
• Sigma Aldrich Chemicals Ltd.
• Thermo Fisher Scientific Inc.

第16章附錄

The global multiplex assays market is forecasted to grow by USD 1414.8 mn during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global multiplex assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of precision medicine approaches, increase in chronic diseases, rising emphasis on early disease diagnosis and preventive care.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global multiplex assays market is segmented as below:

By Type

• Protein multiplex assays
• Nucleic acid multiplex assays
• Cell-based multiplex assays

By Product

• Consumables
• Instruments and accessories
• Services

By Technology

• Flow cytometry
• Multiplex real-time PCR
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of multiplex assays with digital and automated laboratory ecosystems as one of the prime reasons driving the global multiplex assays market growth during the next few years. Also, expansion of spatial biology and multi-omics research applications and growing preference for customized and application-specific assay panels will lead to sizable demand in the market.

The report on the global multiplex assays market covers the following areas:

• Global multiplex assays market sizing
• Global multiplex assays market forecast
• Global multiplex assays market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global multiplex assays market vendors that include Abbott Laboratories, Agilent Technologies Inc., BD Biosciences, Beckman Coulter Inc., Bio Rad Laboratories Inc., BioMerieux SA, DiaSorin SpA, Eurofins Scientific SE, Hologic Inc., Meso Scale Diagnostics LLC, Miltenyi Biotec BV and Co. KG, Promega Corp., QIAGEN N.V., Revvity Inc., Sartorius AG, Seegene Inc., Siemens Healthineers AG, Sigma Aldrich Chemicals Ltd., Tecan Trading AG, Thermo Fisher Scientific Inc.. Also, the global multiplex assays market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Multiplex Assays Market 2020 - 2024
  • Historic Market Size - Data Table on Global Multiplex Assays Market 2020 - 2024 ($ million)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global multiplex assays market
• 6.2 Impact of geopolitical conflicts on global multiplex assays market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Protein multiplex assays - Market size and forecast 2025-2030
• 8.4 Nucleic acid multiplex assays - Market size and forecast 2025-2030
• 8.5 Cell-based multiplex assays - Market size and forecast 2025-2030
• 8.6 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
• 9.2 Comparison by Product
• 9.3 Consumables - Market size and forecast 2025-2030
• 9.4 Instruments and accessories - Market size and forecast 2025-2030
• 9.5 Services - Market size and forecast 2025-2030
• 9.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 Flow cytometry - Market size and forecast 2025-2030
• 10.4 Multiplex real-time PCR - Market size and forecast 2025-2030
• 10.5 Others - Market size and forecast 2025-2030
• 10.6 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Growing adoption of precision medicine approaches
  • Increase in chronic diseases
  • Rising emphasis on early disease diagnosis and preventive care
• 13.2 Market challenges
  • High complexity of data interpretation and result standardization
  • Limited availability of highly skilled technical professionals
  • Stringent regulatory and compliance requirements across regions
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of multiplex assays with digital and automated laboratory ecosystems
  • Expansion of spatial biology and multi-omics research applications
  • Growing preference for customized and application-specific assay panels

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.6 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.7 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 15.8 DiaSorin SpA
  • DiaSorin SpA - Overview
  • DiaSorin SpA - Business segments
  • DiaSorin SpA - Key news
  • DiaSorin SpA - Key offerings
  • DiaSorin SpA - Segment focus
  • SWOT
• 15.9 Eurofins Scientific SE
  • Eurofins Scientific SE - Overview
  • Eurofins Scientific SE - Business segments
  • Eurofins Scientific SE - Key offerings
  • Eurofins Scientific SE - Segment focus
  • SWOT
• 15.10 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Product / Service
  • Hologic Inc. - Key offerings
  • SWOT
• 15.11 Meso Scale Diagnostics LLC
  • Meso Scale Diagnostics LLC - Overview
  • Meso Scale Diagnostics LLC - Product / Service
  • Meso Scale Diagnostics LLC - Key offerings
  • SWOT
• 15.12 Miltenyi Biotec BV and Co. KG
  • Miltenyi Biotec BV and Co. KG - Overview
  • Miltenyi Biotec BV and Co. KG - Product / Service
  • Miltenyi Biotec BV and Co. KG - Key offerings
  • SWOT
• 15.13 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key offerings
  • SWOT
• 15.14 Revvity Inc.
  • Revvity Inc. - Overview
  • Revvity Inc. - Business segments
  • Revvity Inc. - Key offerings
  • Revvity Inc. - Segment focus
  • SWOT
• 15.15 Sartorius AG
  • Sartorius AG - Overview
  • Sartorius AG - Business segments
  • Sartorius AG - Key offerings
  • Sartorius AG - Segment focus
  • SWOT
• 15.16 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.17 Sigma Aldrich Chemicals Ltd.
  • Sigma Aldrich Chemicals Ltd. - Overview
  • Sigma Aldrich Chemicals Ltd. - Product / Service
  • Sigma Aldrich Chemicals Ltd. - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations